A
Acumen Pharmaceuticals D
D
ABOS
1.19000
USD
-0.02
(-1.65%)
مغلق
حجم التداول
8,681
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
72,082,376
العنوان: Acumen Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, isa subclass monoclonal antibody that selectively targets amyloid-beta oligomers.